Montreal, Canada: According to longitudinal data published in the journal, Canadian patients who were licensed to use medical cannabis products reported sustained improvements in their health-related quality of life. Cannabis and cannabinoid research.
A team of researchers at McGill University in Montreal evaluated the safety and efficacy of medical cannabis products in a cohort of 2,991 patients. Subjects in this study consumed cannabis flowers, extracts, or other related products for one year.
Consistent with other studies, researchers report that: -Up. Results also revealed clinically significant improvements in pain interference and fatigue, anxiety, and well-being from baseline. Few patients reported experiencing serious adverse events as a result of cannabis consumption.
The author concludes: [medical cannabis] Appears to be safe and effective within 3 months of initiation for a variety of medical indications, as prescribed by a physician. ”
Data published late last week in the journal JAMA network open reports that nearly 1 in 4 pain sufferers who live in states where access to medical cannabis is legal identify themselves as marijuana consumers.
The full study, The Quebec Cannabis Registry: Investigating the safety and effective of medical cannabis, is published in Cannabis and Cannabinoid Research..